AirSculpt Technologies, Inc. Operating Cash Flow
AirSculpt Technologies, Inc. (AIRS) reported Operating Cash Flow of $4.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.24M, a 124.84% decline year-over-year.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $5.27M, a 507.26% increase year-over-year.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.53M, a 193.29% decline year-over-year.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$225.00K, a 112.30% decline year-over-year.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $3.10M, a 72.72% decline from fiscal 2024.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $11.35M, a 52.62% decline from fiscal 2023.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $23.96M, a 2.01% decline from fiscal 2022.
- AirSculpt Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $24.45M, a 8.21% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $4.03M 10-Q · filed 2026-08-10 | $1.50M derived: sum of 3 quarters · filed 2026-08-10 | $1.28M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $5.27M 10-Q · filed 2026-05-08 | $2.74M derived: sum of 2 quarters · filed 2026-05-08 | $2.52M derived: sum of 3 quarters · filed 2026-05-08 | $7.50M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$2.53M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$2.76M derived: sum of 2 quarters · filed 2026-04-06 | $2.23M derived: sum of 3 quarters · filed 2026-08-10 | $3.10M 10-K/A · filed 2026-04-06 |
| 2025-09-30 | -$225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.76M derived: sum of 2 quarters · filed 2026-08-10 | $5.63M 10-Q · filed 2025-11-07 | $8.34M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.85M 10-Q · filed 2026-08-10 | $8.56M derived: sum of 3 quarters · filed 2026-08-10 | $10.39M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $868.00K 10-Q · filed 2026-05-08 | $3.58M derived: sum of 2 quarters · filed 2026-05-08 | $5.41M derived: sum of 3 quarters · filed 2026-05-08 | $8.85M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.71M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $4.54M derived: sum of 2 quarters · filed 2026-04-06 | $7.99M derived: sum of 3 quarters · filed 2026-04-06 | $11.35M 10-K/A · filed 2026-04-06 |
| 2024-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $5.27M derived: sum of 2 quarters · filed 2025-11-07 | $8.64M 10-Q · filed 2025-11-07 | $13.50M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $6.81M 10-Q · filed 2025-08-01 | $11.67M derived: sum of 3 quarters · filed 2026-04-06 | $12.31M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-03-31 | $3.37M 10-Q · filed 2025-05-02 | $8.23M derived: sum of 2 quarters · filed 2026-04-06 | $8.87M derived: sum of 3 quarters · filed 2026-04-06 | $21.10M derived: sum of 4 quarters · filed 2026-04-06 |
| 2023-12-31 | $4.87M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $5.50M derived: sum of 2 quarters · filed 2026-04-06 | $17.74M derived: sum of 3 quarters · filed 2026-04-06 | $23.96M 10-K/A · filed 2026-04-06 |
| 2023-09-30 | $635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $12.87M derived: sum of 2 quarters · filed 2024-11-08 | $19.09M 10-Q · filed 2024-11-08 | $25.73M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $12.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $18.45M 10-Q · filed 2024-08-09 | $25.09M derived: sum of 3 quarters · filed 2025-03-14 | $25.42M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $6.22M 10-Q · filed 2024-05-10 | $12.86M derived: sum of 2 quarters · filed 2025-03-14 | $13.19M derived: sum of 3 quarters · filed 2025-03-14 | $23.59M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $6.97M derived: sum of 2 quarters · filed 2025-03-14 | $17.37M derived: sum of 3 quarters · filed 2025-03-14 | $24.45M 10-K · filed 2025-03-14 |
| 2022-09-30 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $10.73M derived: sum of 2 quarters · filed 2023-11-13 | $17.81M 10-Q · filed 2023-11-13 | $12.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $17.48M 10-Q · filed 2023-08-11 | $11.77M derived: sum of 3 quarters · filed 2024-02-27 | $20.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $7.08M 10-Q · filed 2023-05-12 | $1.37M derived: sum of 2 quarters · filed 2024-02-27 | $9.90M derived: sum of 3 quarters · filed 2024-02-27 | $24.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.82M derived: sum of 2 quarters · filed 2024-02-27 | $17.45M derived: sum of 3 quarters · filed 2024-02-27 | $26.63M 10-K · filed 2024-02-27 |
| 2021-09-30 | $8.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $23.16M derived: sum of 2 quarters · filed 2022-11-14 | $32.34M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $14.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $23.81M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $9.18M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $13.96M 10-K · filed 2023-03-10 | |||
| 2019-12-31 | $4.94M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |